Pradžia › Antsvoris › Arizona › Phoenix
Antsvoris klinikiniai tyrimai Phoenix, AZ
15 tyrimai dėl Antsvoris ieško dalyvių vietose Phoenix ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Renkami dalyviai3 fazė
- Absolute Clinical Research, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Renkami dalyviai3 fazė
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Renkami dalyviai3 fazė
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Renkami dalyviai3 fazė
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Renkami dalyviai3 fazė
- Elite Clinical Studies, LLC, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Renkami dalyviai3 fazė
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Renkami dalyviai3 fazė
- AURORA-2 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Renkami dalyviai2 fazė
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Renkami dalyviai2 fazė
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Renkami dalyviai4 fazė
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Renkami dalyviai3 fazė
- Kailera Clinical Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Renkami dalyviaiStebimasis tyrimas
- Exponent Phoenix, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Renkami dalyviai3 fazė
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Renkami dalyviai3 fazė
- The University of Arizona College of Medicine- Phoenix, Phoenix
Antsvoris tyrimai kituose miestuose
- San Antonio, TX34 tyrimai
- Houston, TX33 tyrimai
- Chicago, IL28 tyrimai
- Orlando, FL27 tyrimai
- Las Vegas, NV23 tyrimai
- Miami, FL23 tyrimai
- Atlanta, GA20 tyrimai
- Dallas, TX20 tyrimai
- New York City, NY19 tyrimai
- Jacksonville, FL19 tyrimai
- Washington, DC19 tyrimai
- Austin, TX18 tyrimai
Kiti tyrimai Phoenix
- Krūties vėžys25 tyrimai
- Storosios ir tiesiosios žarnos vėžys25 tyrimai
- Nutukimas22 tyrimai
- Nedidelinių ląstelių plaučių vėžys20 tyrimai
- Metastatinis vėžys20 tyrimai
- Širdies nepakankamumas18 tyrimai
- Prostatos vėžys17 tyrimai
- Vėžys (visų tipų)17 tyrimai
- Kartotinė mieloma16 tyrimai
- Kasos vėžys16 tyrimai
- Širdies ir kraujagyslių ligos16 tyrimai
- Alzheimerio liga15 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.